111 related articles for article (PubMed ID: 26447027)
1. Expression of ezrin in oral squamous cell carcinoma: Prognostic impact and clinicopathological correlations.
Safi AF; Nickenig HJ; Rothamel D; Zirk M; Thiele O; Grandoch A; Scheer M; Zinser M; Zöller J; Drebber U; Kreppel M
J Craniomaxillofac Surg; 2015 Nov; 43(9):1899-905. PubMed ID: 26447027
[TBL] [Abstract][Full Text] [Related]
2. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.
Madan R; Brandwein-Gensler M; Schlecht NF; Elias K; Gorbovitsky E; Belbin TJ; Mahmood R; Breining D; Qian H; Childs G; Locker J; Smith R; Haigentz M; Gunn-Moore F; Prystowsky MB
Head Neck; 2006 Nov; 28(11):1018-27. PubMed ID: 16783828
[TBL] [Abstract][Full Text] [Related]
3. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
4. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin, ezrin, and Rho-A proteins may have joint participation in tumor invasion of lip cancer.
Assao A; Nonogaki S; Lauris JRP; Carvalho AL; Pinto CAL; Soares FA; Kowalski LP; Oliveira DT
Clin Oral Investig; 2017 Jun; 21(5):1647-1657. PubMed ID: 27628318
[TBL] [Abstract][Full Text] [Related]
6. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
[TBL] [Abstract][Full Text] [Related]
7. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
[TBL] [Abstract][Full Text] [Related]
8. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.
Song JJ; Zhao SJ; Fang J; Ma D; Liu XQ; Chen XB; Wang Y; Cheng B; Wang Z
BMC Cancer; 2016 Jul; 16():530. PubMed ID: 27457382
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic iASPP expression as a novel prognostic indicator in oral cavity squamous cell carcinoma.
Kim JW; Roh JL; Park Y; Cho KJ; Choi SH; Nam SY; Kim SY
Ann Surg Oncol; 2015 Feb; 22(2):662-9. PubMed ID: 25149434
[TBL] [Abstract][Full Text] [Related]
10. Combined Analysis of Vascular Endothelial Growth Factor Expression with Cyclooxygenase-2 and Mast Cell Density in Oral Squamous Cell Carcinoma.
Akbarzadeh Baghban A; Taghavi N; Shahla M
Pathobiology; 2017; 84(2):80-86. PubMed ID: 27577989
[TBL] [Abstract][Full Text] [Related]
11. Effect of c-Met expression on survival in head and neck squamous cell carcinoma.
Lo Muzio L; Farina A; Rubini C; Coccia E; Capogreco M; Colella G; Leonardi R; Campisi G; Carinci F
Tumour Biol; 2006; 27(3):115-21. PubMed ID: 16612144
[TBL] [Abstract][Full Text] [Related]
12. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
Kumar M; Srivastava G; Kaur J; Assi J; Alyass A; Leong I; MacMillan C; Witterick I; Shukla NK; Thakar A; Duggal R; Roychoudhury A; Sharma MC; Walfish PG; Chauhan SS; Ralhan R
J Transl Med; 2015 Jan; 13():8. PubMed ID: 25591983
[TBL] [Abstract][Full Text] [Related]
14. Expression of Bcl-2 family proteins and association with clinicopathological characteristics of oral squamous cell carcinoma.
Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
Histopathology; 2010 Aug; 57(2):304-16. PubMed ID: 20716171
[TBL] [Abstract][Full Text] [Related]
15. High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma.
Cai M; Tan R; Huang Y; Chen X; Kong Q; Guo K; Xu M
Pathol Oncol Res; 2021; 27():641042. PubMed ID: 34257607
[TBL] [Abstract][Full Text] [Related]
16. Expression of AEG-1 and microvessel density correlates with metastasis and prognosis of oral squamous cell carcinoma.
Xia X; Du R; Zhao L; Sun W; Wang X
Hum Pathol; 2014 Apr; 45(4):858-65. PubMed ID: 24656097
[TBL] [Abstract][Full Text] [Related]
17. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
18. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma.
Lin CY; Jeng YM; Chou HY; Hsu HC; Yuan RH; Chiang CP; Kuo MY
J Surg Oncol; 2008 May; 97(6):544-50. PubMed ID: 18297688
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of beta-2 adrenergic receptor in oral squamous cell carcinoma.
Bravo-Calderón DM; Oliveira DT; Marana AN; Nonogaki S; Carvalho AL; Kowalski LP
Cancer Biomark; 2011-2012; 10(1):51-9. PubMed ID: 22297552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]